These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11102777)

  • 1. Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases.
    Illei GG; Lipsky PE
    Curr Opin Immunol; 2000 Dec; 12(6):712-8. PubMed ID: 11102777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cytokine vaccination: a new biotherapy of autoimmunity?
    Semerano L; Assier E; Boissier MC
    Autoimmun Rev; 2012 Sep; 11(11):785-6. PubMed ID: 22349621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
    Jorgensen C; Apparailly F; Sany J
    Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909
    [No Abstract]   [Full Text] [Related]  

  • 4. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.
    Feldmann M; Maini RN
    Nat Med; 2003 Oct; 9(10):1245-50. PubMed ID: 14520364
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
    Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
    J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current conception of rheumatoid polyarthritis treatment: towards a therapeutic revolution?].
    Sany J
    Bull Acad Natl Med; 2003; 187(5):957-73; discussion 973-6. PubMed ID: 14979059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM; Perry CM
    BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological profile of anti-human TNF alpha monoclonal antibody, infliximab (Remicade)].
    Sugita T
    Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):57-64. PubMed ID: 12617039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-TNF-alpha antibody therapies in autoimmune diseases.
    Chatzantoni K; Mouzaki A
    Curr Top Med Chem; 2006; 6(16):1707-14. PubMed ID: 17017952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and nature of infectious disease in patients treated with anti-TNF agents.
    Raychaudhuri SP; Nguyen CT; Raychaudhuri SK; Gershwin ME
    Autoimmun Rev; 2009 Dec; 9(2):67-81. PubMed ID: 19716440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7th International Immunoglobulin Conference: Immunomodulation.
    Danieli MG; Shoenfeld Y
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):123. PubMed ID: 25546788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibodies in chronic autoimmune inflammatory diseases].
    Semerano L; Boissier MC
    Med Sci (Paris); 2009 Dec; 25(12):1108-12. PubMed ID: 20035687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO; Paleolog E; Feldmann M
    Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease.
    Pouillon L; Bossuyt P; Peyrin-Biroulet L
    Expert Opin Biol Ther; 2016 Oct; 16(10):1277-90. PubMed ID: 27329436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
    Selmaj K; Raine CS; Cross AH
    Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-targeted immunotherapy.
    Janson RW; Arend WP
    Bull Rheum Dis; 1992; 41(3):6-8. PubMed ID: 1617334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific therapy for autoimmune disease.
    Harrison LC; Hafler DA
    Curr Opin Immunol; 2000 Dec; 12(6):704-11. PubMed ID: 11102776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.